No Data
No Data
Nomura decrases its stake in NEXTAGE(3186.JP) to 4.31%
On Nov 6, Nomura and related parties submitted the Change Report to Ministry of Finance. The report shows that Nomura and related parties decreased their holdings in $NEXTAGE(3186.JP)$, with their
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
Buy conversion brand list market Code Brand name Closing price SAR Tohsho main board <1419> Tamahome 3850 3695 <167A> Ryosan Hisho 2582 2437 <1802> Obayashi Construction 1891 1791 <1852> Asanuma Construction 664 642 <1860> Toda Construction 928 890 <1888> Wakuchiku Construction 3575 3385 <1893> Go Yo Construction 637 616 <1938> Nikko Real Tech 1045 10
Driven by the weak yen, the consumer spending of tourists visiting Japan in the first 9 months has reached a new high.
①Driven by the weakness of the Japanese yen, Japan's tourism industry is extremely hot in 2024; ②Data shows that as of September, international tourists spent 5.86 trillion yen in Japan (equivalent to 39.27 billion US dollars); ③This exceeded the consumption record of 5.3 trillion yen set for the full year of 2023.
Adastria hits new highs [stocks hitting new highs and lows].
The new high stock of the Tokyo Stock Exchange Prime is Adastria <2685>, Par Group Holdings <2726> with 20 stocks. The new low stock of the Tokyo Stock Exchange Prime is Warabe Ya Nichiyo Holdings <2918>, Nextage <3186> with 10 stocks. "Tokyo Stock Exchange Prime," "Tokyo Stock Exchange Standard," "Tokyo Stock Exchange Growth" new highs, new lows, new highs, new lows, new highs, new lows 10/17 20 10 51 33 17 10/16 36 11 11 15 61 41 10/15 57 51
Stocks that moved the previous day part1 include Shochiku, AeroEdge, Koshidaka HD, etc.
Stock name <Code> 11th closing price ⇒ Previous day comparison Shochiku <9601> 9246 -106925 Financial estimates for the fiscal year ending February 25 have been revised downward. Vitz <4440> 840 +30 Operating profit is expected to increase by 50.6% in the previous period and 19.6% in this period. Part-time Thai <2341> 143 -8 The operating profit for the first half decreased by 98.2%, expanding the decrease rate from 80.3% in the first quarter. Chordia <190A> 296 -38 At the Japan Society of Hematology Academic Meeting, the first-phase clinical trial of the CLK inhibitor CTX-712.
Shimamura, SoftBank G (additional) Rating
Target stock price change code | Stock name | Securities company | Previous | After the change | ------|-----------------|----------|--------|--------|<4021>|Nissan Chemical | Citi | 5600 yen | 5900 yen |<4631>|DIC | Mizuho | 3400 yen | 3900 yen |<6432>|Takeuchi Manufacturing | GS |
No Data
No Data